Hepatic metastases from breast cancer

被引：20

作者：

Rubino A. ^{[1
,5
]}

Doci R. ^{[1
]}

Foteuh J.C. ^{[1
]}

Morenghi E. ^{[2
]}

Fissi S. ^{[3
]}

Giorgetta C. ^{[3
]}

Abumalouh I. ^{[1
]}

Di Tommaso L. ^{[4
]}

Gennari L. ^{[1
]}

机构：

[1] Department of General Surgery i, IRCCS Istituto Clinico Humanitas, Rozzano, Milan

[2] Biostatistic Unit, IRCCS Istituto Clinico Humanitas, Rozzano, Milan

[3] Department of General Surgery i, A. Manzoni Hospital, Lecco

[4] Department of Anatomic Pathology, IRCCS Istituto Clinico Humanitas, Rozzano, Milan

[5] Department of Senology, Istituto Clinico Humanitas, 20089 Rozzano, Milan

来源：

Updates in Surgery | 2010年 / 62卷 / 3-4期

关键词：

Breast; Liver metastases; Liver resection; Treatment;

D O I：

10.1007/s13304-010-0026-7

中图分类号：

学科分类号：

摘要：

The prognosis of patients with hepatic metastasis from breast cancer treated with systemic or regional chemotherapy is disappointing. When technically feasible, liver resection offers the best results. Eighteen patients out of 22 submitted to laparotomy underwent radical liver resection. Median follow-up from liver resection was 36 months. The median time interval between breast cancer diagnosis and disease recurrence was 35 months. Median disease-free survival and overall survival from liver resection were 66 and 74 months, respectively. Median survival time from breast cancer surgery was 88.5 months. Surgical treatment of liver metastases should be carried out on young and older patients alike when site of metastases is the liver alone. Neoadjuvant treatment and preoperative diagnostic laparoscopy should be planned in future experience. © 2010 Springer-Verlag.

引用

页码：143 / 148

页数：5

共 50 条

[41] Hepatic arterial therapy with oxaliplatin and systemic capecitabine for patients with liver metastases from breast cancer
Lindgaard, S. C.
Brinch, C. M.
Jensen, B. K.
Norgaard, H. H.
Hermann, K. L.
Theile, S.
Larsen, F. O.
Jensen, B., V
Michelsen, H.
Nelausen, K. M.
Holm, V. H.
Ekblad, L.
Soerensen, Peter G.
Nielsen, D. L.
BREAST, 2019, 43 : 113 - 119
[42] Radiographically occult, diffuse hepatic metastases from breast cancer: Case report and brief review
Noronha, Helio
Fonseca, Allex J.
de Oliveira, Ivanir M.
ANNALS OF ONCOLOGY, 2006, 17 : 90 - 90
[43] INTRA-ARTERIAL (IA) CHEMOTHERAPY (CH) OF HEPATIC METASTASES FROM BREAST-CANCER
MARAL, J
BOUSQUET, JC
BAUMER, R
CURET, P
WEIL, M
JACQUILLAT, C
BREAST CANCER RESEARCH AND TREATMENT, 1984, 4 (04) : 349 - 349
[44] Hepatic Resection is Safe for Metachronous Hepatic Metastases from Ovarian Cancer
Guang-cai Niu
Chang-ming Shen
Wei Cui
Qiang Li
Cancer Biology & Medicine, 2012, (03) : 182 - 187
[45] Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer
Bartlett, DL
Libutti, SK
Figg, WD
Fraker, DL
Alexander, HR
SURGERY, 2001, 129 (02) : 176 - 187
[46] Hepatic Artery Infusion as Treatment of Hepatic Metastases from Colorectal Cancer
Kemeny M.M.
Journal of Gastrointestinal Surgery, 1997, 1 (5) : 423 - 425
[47] Hepatic Resection is Safe for Metachronous Hepatic Metastases from Ovarian Cancer
Guang-cai Niu
Chang-ming Shen
Wei Cui
Qiang Li
Cancer Biology & Medicine, 2012, 9 (03) : 182 - 187
[48] HEPATIC METASTASECTOMY IN BREAST CANCER LIVER METASTASES: ONE CENTER EXPERIENCE
Fernandes, Ana Catarina
Capela, Andreia
Augusto, Isabel
Caeiro, Claudia
Damasceno, Margarida
Melo, Renato Bessa
BREAST, 2013, 22 : S36 - S36
[49] A patient with breast cancer with hepatic metastases and a complete response to herceptin as monotherapy
Escalante S.M.
Lescure Á.R.
Sanz V.P.
Banaclocha N.M.
Ponce C.G.
Mena A.C.
Clinical and Translational Oncology, 2006, 8 (10) : 761 - 763
[50] Hepatic Arterial Infusion and Systemic Chemotherapy for Breast Cancer Liver Metastases
Ang, Celina
Jhaveri, Komal
Patel, Dina
Gewirtz, Alexandra
Seidman, Andrew
Kemeny, Nancy
BREAST JOURNAL, 2013, 19 (01): : 96 - 99

← 1 2 3 4 5 →